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Introduction
Cardiac computed tomography angiography (cardiac CTA) has emerged as a noninvasive imaging method with numerous indications and fields of application. 1, 2 Most commonly, cardiac CTA is used for the evaluation of the coronary arteries to diagnose coronary artery stenosis. In particular, for patients with suspected coronary artery diseases, coronary CTA reaches high sensitivity and negative predictive value, thereby possibly avoiding invasive coronary angiography. 3 Due to the rapidly increasing volume of cardiac CTAs performed, safety considerations are an important concern, especially for the cohort of younger patients with low likelihood of disease. In this regard, ionizing radiation exposure during cardiac CTA has to be taken into account, because this is known to potentially amplify long-term carcinogenesis in a dose-dependent manner. 4 One decade ago, the radiation dose exposure of cardiac CTA in daily clinical practice was evaluated in a large prospective multicenter registry (PROTECTION I study). 5 Shortly before that time, 64-slice CT scanners had been introduced and dual-source CT scanning became available, enabling improved imaging of cardiac morphology and function at higher temporal resolution. 6, 7 In 2007, radiation doses during cardiac CTA varied substantially between study sites, and the utilization of dose-saving protocols differed significantly. 5 This suggested a large potential for dose reduction in cardiac CTAs.
Since 2007, dose-saving strategies and protocols have been widely implemented, paving the way for potential reductions of radiation dose exposure (Table 1a) .
Improved CT modifications and software include low tube current imaging, decreased tube voltage, automatic dose modulation with tube current adjustment to the patients' size and shape and electrocardiography (ECG)-controlled tube current modulation. 8, 9 Another major improvement has been the utilization of iterative image reconstruction with advanced raw data processing, which leads to decreased image noise in lowcontrast areas and enables additional radiation dose reduction. 10 Improved cardiac CTA protocols with radiation exposure only during mid-diastole (prospectively ECGtriggered axial scanning) or solely during one cardiac cycle (prospectively ECGtriggered high-pitch spiral scanning) further enable significant dose savings. 11, 12 Beyond that, CT hardware and design, including wide detector imaging, as well as patient-and case-related factors contribute to the level of radiation dose exposure (Table 1b) . Certainly, utilization of ionizing radiation always has to be considered M A N U S C R I P T
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3 critically and the use of appropriateness and acquisition guidelines is recommended in clinical decision-making. 13, 14 Cardiologists and radiologists utilize the procedural improvements described to minimize radiation dose, whilst still maintaining diagnostic image quality. Thus, clinicians aim to reduce radiation dose exposure to be "as low as reasonably achievable" (ALARA principle). 15 Since 2007, several randomized clinical trials have demonstrated the maintenance of diagnostic image quality for the utilization of different dose-saving techniques in cardiac CTA imaging. 12, [16] [17] [18] [19] [20] These studies also proved that dose-saving techniques may be combined using CT platforms from different vendors. Recent experimental single-center data demonstrated a tremendous reduction of radiation dose exposure in cardiac CTA in carefully selected patients. 21, 22 Since 2007, however, no studies have investigated the radiation dose exposure associated with cardiac CTA in daily practice in a large, multicenter approach and acquired data for comprehensive evaluation of various dose-saving techniques and their impact on image quality. We therefore designed an international prospective multicenter study, PROTECTION VI, to evaluate radiation dose exposure and the application of dose-saving strategies worldwide. We herein report the objectives, methodology, and rationale for this study.
Overall study design
The PROTECTION VI trial is a prospective, worldwide, multicenter, observational, and multi-vendor registry evaluating the radiation dose exposed from cardiac CTA in current daily practice. The study is independent from industry funding.
Participating study sites
For this study cardiologists and radiologists from all around the world have been 
Target population
The study is targeted to subjects undergoing cardiac CT angiography in daily clinical routine. Inclusion criteria are a clinical indication for cardiac CTA including evaluation of the coronary arteries or other cardiac structures with scanning of the heart.
Performance of cardiac CTA will be standard of clinical care without external influence by the core laboratory.
Study objectives
The primary objective of the PROTECTION VI study is to collect and analyze radiation dose exposure data from cardiac CTA in current daily practice. It will also assess the variability of radiation dose estimates between study sites, countries, continents, different CT systems and CT vendors. We will relate the experience of participating study sites to the radiation dose exposure. The cardiac CT scan length and the relationship between scan and heart length will be assessed. Specifically, the study will assess the utility of the various dose-saving strategies. Further, the relationship between image quality and radiation dose estimates will be explored.
The study will also assess whether a cardiac CTA scans is diagnostic or if repeat scans are necessary. The primary and secondary endpoints of the study are summarized in Table 2 .
Methods
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Patient recruitment and evaluation
Participating study sites were asked to enroll consecutive patients and collect data that are transferred and evaluated at a central core laboratory (Figure 1) . image quality assessment and evaluation of dose-saving strategies will be carried out.
Estimation of radiation dose
Local investigators from the participating study sites obtain radiation dose parameters including the volume CT dose index (CTDI vol ) and the dose length product (DLP) from the scan protocol generated by the CT system after each cardiac CTA study. The effective dose will be estimated from the DLP in combination with an appropriate organ-weighting factor of the chest as the investigated anatomic region.
Besides the pure estimation of the radiation dose exposed from cardiac CTA studies, influencing factors such as patient characteristics, clinical indication, scans from different CT systems and vendors, CT protocols, application of dose-saving strategies and experience of the investigators will be evaluated. Radiation dose will be calculated separately according to the clinical indication. Signal-to-noise ratio will be calculated as mean CT attenuation value within the left ventricle divided by image noise.
Measurement of image quality
Statistical considerations
Univariate and multivariate analyses will be performed to identify predictors significantly associated with radiation dose. To avoid overfitting, only variables with p<0.1 in the univariate model will be entered into the multivariate model. A generalized estimation equation model will be used to account for the clustering effect of this multicenter trial. All statistical analysis will be performed using R version 3.4.1 or newer. 23 
Organization and data management
The study protocol has been approved by each participating center and was handed to the local ethics committee or local IRB for review and approval. An Executive Steering Committee composed of a group of physicians with expertise in cardiac CTA, clinical research and statistics supervises the study. The Executive Steering Committee is tasked with oversight of the study design, conduct of the registry, final review of data as well as presentation and publication of results. This study has been registered with clinicaltrials.gov (NCT02996903).
Summary and conclusions
The PROTECTION VI study will investigate the current radiation dose of cardiac CTA Overview of the data acquisition and processing scheme including multicenter patient enrollment, data collection at local study sites, data transfer and data evaluation in a central core laboratory.
